How have SBMFF shares performed in 2024?

Sino Biopharmaceutical's stock was trading at $0.4157 at the start of the year. Since then, SBMFF stock has decreased by 24.2% and is now trading at $0.3150. View the best growth stocks for 2024 here .

How do I buy shares of Sino Biopharmaceutical?

Shares of SBMFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:SBMFF

Sino Biopharmaceutical (SBMFF) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free SBMFF Stock Alerts

$0.31

-0.03 (-8.70%)

(As of 04/19/2024 ET)

Compare

Today's Range: $0.31
▼
$0.31
50-Day Range: $0.31
▼
$0.42
52-Week Range: $0.32
▼
$0.54

Volume: 500 shs
Average Volume: 4,900 shs
Market Capitalization: $5.93 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials Headlines SEC Filings Short Interest

Get Sino Biopharmaceutical alerts:

Ad TradeSmith

A.I. Pioneer Issues Urgent Warning to Americans

With artificial intelligence creeping into every facet of our lives, what should you be doing to "A.I.-Proof" your future? It's the question on many of our minds.

Click here to see Louis' new video for yourself.

About Sino Biopharmaceutical Stock (OTCMKTS:SBMFF)

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection. It also provides surgery/analgesia medicines comprising Debaian cataplasms and Gaisanchun soft capsules; and cardio-cerebral vascular medicines, including Yilunping and Kaina tablets. In addition, the company is involved in the long term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.

SBMFF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

SBMFF Stock News Headlines

February 6, 2024 | reuters.com

Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln

February 6, 2024 | news.yahoo.com

Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 million

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

January 30, 2024 | wsj.com

Sino Biopharmaceutical Ltd.

December 29, 2023 | markets.businessinsider.com

Jefferies Keeps Their Buy Rating on Sino Biopharmaceutical (SBMFF)

December 15, 2023 | bbc.co.uk

Birmingham's Ahmad Al Sino jailed for relative's wedding row murder

November 7, 2023 | finance.yahoo.com

Hong Kong Shares Turn Higher as Lower Oil Prices, Treasury Yields Support

October 4, 2023 | finance.yahoo.com

Insights into Sino Biopharmaceutical Ltd's Dividend Performance

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

September 29, 2023 | uk.investing.com

Sino Logistics Corporation PCL (SINO)

September 13, 2023 | jp.reuters.com

Sino Biopharmaceutical Ltd

July 17, 2023 | investing.com

Sino Biopharmaceutical Ltd ADR (SBHMY)

May 30, 2023 | forbes.com

Sino-Forest

March 12, 2023 | finance.yahoo.com

Sino Biopharmaceutical Limited (1177.HK)

March 7, 2023 | msn.com

Sino Biopharm Wins CFIUS Approval for $161 Million F-Star Deal

January 26, 2023 | finance.yahoo.com

invoX Pharma and F-star Therapeutics issue Joint Statement

November 11, 2022 | seekingalpha.com

F-star Therapeutics: At A Discount Of >30% To Takeover Offer, With CFIUS Approval On The Horizon

August 28, 2022 | finance.yahoo.com

China's CanSinoBIO H1 revenue drops on weaker COVID shot demand

July 18, 2022 | benzinga.com

Sino Biopharmaceutical (OTC:SBMFF), Short Interest Report

July 18, 2022 | benzinga.com

Sino Biopharmaceutical (OTC:SBMFF), Analyst Ratings, Price Targets, Predictions

June 26, 2022 | seekingalpha.com

Week In Review: invoX, A Sino Biopharm Company, To Pay $161 Million To Acquire F-Star

June 23, 2022 | benzinga.com

The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise

June 23, 2022 | marketwatch.com

Sino Biopharmaceutical Unit to Buy F-star Therapeutics for $161 Million >FSTX

June 23, 2022 | seekingalpha.com

Sino Biopharma to acquire F-star Therapeutics for $161M

June 23, 2022 | benzinga.com

F-star Therapeutics Shares Are Rallying Today - Read Why

January 12, 2022 | nasdaq.com

Sino Biopharmaceutical Ltd. (SBMFF)

August 31, 2021 | markets.businessinsider.com

Sino Biopharmaceutical is about to announce earnings — here's what Wall Street expects

See More Headlines

Receive SBMFF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sino Biopharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: OTCMKTS:SBMFF
Previous Symbol: NASDAQ:SBMFF
CUSIP: N/A
CIK: 1604982
Web: www.sinobiopharm.com
Phone: 852-2802-9886
Fax: 852-2880-0847
Employees: 25,806
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 18,813,870,000
Free Float: N/A
Market Cap: $6.57 billion
Optionable: Not Optionable
Beta: 0.45

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Ms. Y. Y. Tse (Age 32)
Executive Chairwoman of the Board
Comp: $5.48M
Ms. Cheung Ling Cheng (Age 60)
Executive Vice Chairwoman of the Board
Comp: $4.86M
Ms. Mingqin Li (Age 65)
Senior VP & Executive Director
Comp: $165.76k
Mr. Zhoushan Tian (Age 60)
Executive Director
Comp: $258.45k
Mr. Hsin Tse (Age 54)
Senior VP & Executive Director
Comp: $832.53k
Mr. Eric S. Y. Tse (Age 28)
CEO & Executive Director
Comp: $3.19M
Mr. Ping Tse (Age 72)
Founder & Senior Executive Vice Chairman
Comp: $5.79M
Ms. Chun Ling Li (Age 52)
Chief Financial Officer
Sean Chen
Chief Strategy Officer
Orphanides George
Chief Scientific Advisor of invoX

Key Competitors

View All Competitors

SBMFF Stock Analysis - Frequently Asked Questions

How have SBMFF shares performed in 2024?: Sino Biopharmaceutical's stock was trading at $0.4157 at the start of the year. Since then, SBMFF stock has decreased by 24.2% and is now trading at $0.3150.
View the best growth stocks for 2024 here.
How do I buy shares of Sino Biopharmaceutical?: Shares of SBMFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:SBMFF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial